Skin cancer of the breast
Pro Research Analysisby 
Searched over 200M research papers
Breast Cancer and Skin Involvement: Incidence and Types
Breast cancer is the most common malignancy in women and is also the leading cancer to metastasize to the skin, accounting for about 30% of all cutaneous metastases in women. The incidence of skin metastases from breast cancer ranges from 0.6% to 10.4% and can occur at any stage of the disease, including as the first sign of recurrence or progression 1368.
Clinical Presentations of Skin Cancer Related to Breast Cancer
Skin involvement in breast cancer can present in many ways. The most common manifestation is the appearance of metastatic nodules, but other forms include erythematous plaques, ulcerated lesions, diffuse skin thickening, and even benign-appearing skin changes that can make diagnosis challenging 1346+1 MORE. Some rare presentations include paraneoplastic dermatoses such as erythema gyratum repens, dermatomyositis, and acquired ichthyosis, which can serve as markers for underlying breast malignancy 48. Mammary Paget’s disease and Cowden syndrome are also associated with specific skin findings and an increased risk of breast cancer .
Diagnostic Challenges and Importance of Early Recognition
Because skin metastases can mimic benign skin conditions or primary skin cancers, early recognition of their diverse clinical and radiological features is crucial for timely diagnosis and management. Imaging studies such as mammography, ultrasound, CT, and MRI can help identify skin thickening, nodules, and infiltration into subcutaneous tissues 38. Histological examination is often necessary to distinguish metastatic breast cancer from primary skin cancers, especially in cases where the metastatic lesion resembles primary skin tumors, such as mucinous carcinoma .
Skin Toxicity and Secondary Skin Cancers After Breast Cancer Treatment
Radiation therapy for breast cancer can cause a range of skin toxicities, from mild erythema to severe ulceration and fibrosis. Newer techniques like helical tomotherapy IMRT have been shown to reduce acute skin toxicity compared to traditional methods, though late toxicities remain similar 79. Importantly, patients who receive radiation therapy for breast cancer have a higher risk of developing secondary nonkeratinocyte skin cancers, such as melanoma and angiosarcoma, although these are rare 29.
Management of Skin Involvement in Breast Cancer
Palliative radiotherapy is a safe and effective option for managing breast cancer with skin involvement, providing significant relief from symptoms like discharge, bleeding, and pain. Higher radiation doses (BED ≥75 Gy) are associated with better local control of skin lesions without increasing severe skin toxicity . Dermatologists play a key role in identifying, diagnosing, and managing both the initial presentation and treatment-related skin complications in breast cancer patients 89.
Conclusion
Skin cancer of the breast encompasses a spectrum of conditions, from direct metastases of breast cancer to the skin, to secondary skin cancers following treatment. The clinical presentations are diverse, making early recognition and accurate diagnosis essential for effective management. Advances in radiotherapy have improved the management of skin toxicity, and awareness of secondary skin cancer risks is important for long-term follow-up. Dermatologists and oncologists must work together to ensure optimal care for patients with breast cancer and skin involvement.
Sources and full results
Most relevant research papers on this topic